Liu et al., via in vitro and in vivo experiments demonstrated that overexpression of SOCS2 inhibited HCC cell proliferation and migration, whereas SOCS2 knock‐down promoted HCC tumorigenesis suggesting that SOCS2 may act as a potential HCC prognostic biomarker [38]. The gene discussed is SOCS2; the disease is hepatocellular carcinoma.